Literature DB >> 13999544

Termination of acquired immunological tolerance to protein antigens following immunization with altered protein antigens.

W O WEIGLE.   

Abstract

Acquired tolerance to BSA in rabbits was terminated following the injection of certain preparations of altered BSA. Injections of Freund's adjuvant containing BSA complexed to anti-BSA, heat-denatured BSA, acetyl-BSA, picryl-BSA, or arsanil-BSA failed to terminate the tolerant state. Except in an occasional tolerant rabbit, injections of these preparations failed to cause the production of precipitating antibody to the altered preparation. Similar results were obtained following injections of alum-precipitated preparations of pepsin-degraded BSA, acetyl-BSA, and picryl-BSA. Injections of Freund's adjuvant containing sulfanil-BSA terminated the tolerant state, but only small amounts of non-precipitating anti-BSA were produced. Injections of Freund's adjuvant containing picryl-acetyl-BSA terminated the tolerant state in two of six rabbits, but again, only small amounts of non-precipitating anti-BSA were produced. Injections of an alum-precipitated preparation of picryl-acetyl-BSA failed to terminate the tolerant state. On the other hand, injections of Freund's adjuvant containing arsanil-sulfanil-BSA terminated the tolerant state in eleven of eleven rabbits and caused the production of precipitating anti-BSA in all nine of the rabbits tested. The tolerant state was terminated also in six of six rabbits injected with an alum-precipitated preparation of arsanil-sulfanil-BSA. Only one of these rabbits produced precipitating anti-BSA. In addition, the injection of BGG-tolerant rabbits with arsanil-BGG, sulfanil-BGG, or arsanil-sulfanil-BGG terminated the tolerant state. These results were discussed in relation to both the clonal selection theory of antibody production and autoimmunity.

Entities:  

Keywords:  IMMUNITY; SERUM ALBUMIN, BOVINE

Mesh:

Substances:

Year:  1962        PMID: 13999544      PMCID: PMC2137579          DOI: 10.1084/jem.116.6.913

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Immunochemical properties of the cross-reactions between anti-BSA and heterologous albumins.

Authors:  W O WEIGLE
Journal:  J Immunol       Date:  1961-11       Impact factor: 5.422

2.  Effect of neonatal injections of protein on the immune response to protein-hapten complexes.

Authors:  S V BOYDEN; E SORKIN
Journal:  Immunology       Date:  1962-05       Impact factor: 7.397

3.  Effects of cysteine and acetic anhydride on the antigenic and catalytic sites of dog intestinal alkaline phosphatase.

Authors:  M SCHLAMOWITZ
Journal:  J Immunol       Date:  1959-07       Impact factor: 5.422

4.  The antibody response of lymph node cells transferred to tolerant recipients.

Authors:  W O WEIGLE; F J DIXON
Journal:  J Immunol       Date:  1959-06       Impact factor: 5.422

5.  [Electrophoresis on agar & immunoelectrophoresis in the comparative study of the degradation of human serum albumin by pepsin, trypsin & chymotrypsin].

Authors:  M KAMINSKI; C E TANNER
Journal:  Biochim Biophys Acta       Date:  1959-05

6.  Modified bovine serum albumin. I. Preparation and physicochemical studies of some derivatives.

Authors:  S EHRENPREIS; P H MAURER; J SRI RAM
Journal:  Arch Biochem Biophys       Date:  1957-03       Impact factor: 4.013

7.  Immediate reactions in the skin of experimental animals provoked by antibody-antigen interaction.

Authors:  Z OVARY
Journal:  Prog Allergy       Date:  1958

8.  Elimination of heterologous proteins from blood of normal, x-radiated and tolerant rabbits.

Authors:  W O WEIGLE; F J DIXON
Journal:  Proc Soc Exp Biol Med       Date:  1958-06

9.  Acquired immune tolerance to human albumin and the response to subsequent injections of diazo human albumin.

Authors:  B CINADER; J M DUBERT
Journal:  Br J Exp Pathol       Date:  1955-10

10.  Some quantitative aspects of the reaction of diazonium compounds with serum albumin.

Authors:  E W GELEWITZ; W L RIEDEMAN; I M KLOTZ
Journal:  Arch Biochem Biophys       Date:  1954-12       Impact factor: 4.013

View more
  38 in total

1.  How infection can trigger autoimmunity.

Authors:  G R Burgio; A G Ugazio
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  STUDIES ON THE TERMINATION OF ACQUIRED TOLERANCE TO SERUM PROTEIN ANTIGENS FOLLOWING INJECTION OF SEROLOGICALLY RELATED ANTIGENS.

Authors:  W O WEIGLE
Journal:  Immunology       Date:  1964-05       Impact factor: 7.397

3.  THE IMMUNE RESPONSE TO AZO-PROTEIN CONJUGATES IN RABBITS UNRESPONSIVE TO THE PROTEIN CARRIERS.

Authors:  D NACHTIGAL; M FELDMAN
Journal:  Immunology       Date:  1964-11       Impact factor: 7.397

4.  ALTERATIONS IN ALBUMIN METABOLISM AFTER SERUM AND ALBUMIN INFUSIONS.

Authors:  M A ROTHSCHILD; M ORATZ; C EVANS; S S SCHREIBER
Journal:  J Clin Invest       Date:  1964-10       Impact factor: 14.808

5.  THE SIGNIFICANCE OF THE PROTEIN CARRIER IN THE STIMULATION OF DNA SYNTHESIS BY HAPTEN-PROTEIN CONJUGATES IN THE SECONDARY RESPONSE.

Authors:  R W DUTTON; H N BULMAN
Journal:  Immunology       Date:  1964-01       Impact factor: 7.397

Review 6.  Development of tRNA synthetases and connection to genetic code and disease.

Authors:  Paul Schimmel
Journal:  Protein Sci       Date:  2008-09-02       Impact factor: 6.725

7.  The mechanism of breakdown of immune tolerance to a protein antigen in rabbits.

Authors:  D Nachtigal
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

Review 8.  Recent observations and concepts in immunological unresponsiveness and autoimmunity.

Authors:  W O Weigle
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

9.  The effect of cross-reacting antigens on the tolerant state.

Authors:  B Cinader; J E St Rose; M Yoshimura
Journal:  J Exp Med       Date:  1967-06-01       Impact factor: 14.307

10.  [Antifertility effect of an active immunization of monkeys with human pregnancy-specific beta 1-glycoprotein (SP1) (author's transl)].

Authors:  H Bohn; E Weinmann
Journal:  Arch Gynakol       Date:  1976-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.